公开(公告)号：BR9815296A

公开(公告)日：2001-11-20

申请号：BR9815296

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： WINN MARTIN ,  BOYD STEVEN A ,  HUTCHINS CHARLES W ,  JAE HWAN-SOO ,  TASKER ANDREW S ,  GELDERN THOMAS W VON ,  KESTER JEFFREY A ,  SORENSEN RYAN K ,  SZCZEPANKIEWICZ BRUCE G ,  HENRY KENNETH J ,  LIU GANG ,  WITTENBERGER STEVEN J ,  KING STEVEN A

IPC: C07D491/048 ,  A61K31/40 ,  A61K31/41 ,  A61K31/423 ,  A61K31/435 ,  A61K31/4355 ,  A61K31/495 ,  A61K31/506 ,  A61K31/535 ,  A61K31/55 ,  A61P1/00 ,  A61P1/04 ,  A61P7/02 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P9/14 ,  A61P13/08 ,  A61P13/12 ,  A61P21/00 ,  A61P21/04 ,  A61P25/06 ,  A61P35/00 ,  A61P43/00 ,  C07D207/16 ,  C07D207/26 ,  C07D207/27 ,  C07D403/04 ,  C07D405/00 ,  C07D405/04 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14 ,  C07D491/056

公开(公告)号：CZ2000348A3

公开(公告)日：2001-03-14

申请号：CZ2000348

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： WINN MARTIN ,  BOYD STEVEN A ,  HUTCHINS CHARLES W ,  JAE HWAN-SOO ,  TASKER ANDREW S ,  VON GELDERN THOMAS W ,  KESTER JEFFREY A ,  SORENSEN BRYAN K ,  SZCZEPANKIEWICZ BRUCE G ,  HENRY KENNETH J ,  LIU GANG ,  WITTENBERGER STEVEN J ,  KING STEVEN A

IPC: A61K31/40 ,  A61K31/445 ,  A61P7/02 ,  A61P9/00 ,  A61P37/00 ,  C07D207/16 ,  C07D403/04 ,  C07D405/04 ,  C07D405/14 ,  C07D417/14

公开(公告)号：AU725122B2

公开(公告)日：2000-10-05

申请号：AU2034499

申请日：1999-03-10

Applicant: ABBOTT LAB

Inventor： WINN MARTIN ,  BOYD STEVEN A ,  HUTCHINS CHARLES W ,  JAE HWAN-SOO ,  TASKER ANDREW S ,  VONGELDERN THOMAS W ,  KESTER JEFFREY A ,  SORENSEN BRYAN K

IPC: A61K31/40 ,  A61K31/402 ,  A61K31/4025 ,  A61K31/403 ,  A61K31/41 ,  A61K31/415 ,  A61K31/422 ,  A61K31/435 ,  A61K31/44 ,  A61K31/4439 ,  A61K31/445 ,  A61K31/454 ,  A61K31/47 ,  A61K31/505 ,  A61K31/506 ,  A61K31/535 ,  A61K31/5377 ,  A61P9/00 ,  A61P9/04 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D20060101 ,  C07D207/14 ,  C07D207/16 ,  C07D401/04 ,  C07D403/04 ,  C07D405/04 ,  C07D405/10 ,  C07D405/14 ,  C07D413/04 ,  C07D419/04 ,  C07D471/04 ,  C07F9/572 ,  C07F9/59

公开(公告)号：ZA9806908B

公开(公告)日：1999-04-26

申请号：ZA9806908

申请日：1998-07-31

Applicant: ABBOTT LAB

Inventor： WINN MARTIN ,  BOYD STEVEN A ,  HUTCHINS CHARLES W ,  JAE HWAN-SOO ,  TASKER ANDREW S ,  GELDERN THOMAS W VON ,  KESTER JEFFREY A ,  SORENSEN BRYAN K ,  SZCZEPANKIEWICZ BRUCE G ,  HENRY KENNETH J ,  LIU GANG ,  WITTENBERGER STEVEN J ,  KING STEVEN A

IPC: A61K20060101 ,  C07D20060101 ,  C07F20060101 ,  C07D ,  A61K ,  C07F

CPC classification number: Y02P20/55

公开(公告)号：CA2297894A1

公开(公告)日：1999-02-11

申请号：CA2297894

申请日：1998-07-27

Applicant: ABBOTT LAB

Inventor： SZCZEPANKIEWICZ BRUCE G ,  SORENSEN BRYAN K ,  WINN MARTIN ,  HENRY KENNETH J ,  KESTER JEFFREY A ,  BOYD STEVEN A ,  HUTCHINS CHARLES W ,  WITTENBERGER STEVEN J ,  KING STEVEN A ,  GELDERN THOMAS W VON ,  TASKER ANDREW S ,  JAE HWAN-SOO ,  LIU GANG

IPC: C07D491/048 ,  A61K31/40 ,  A61K31/41 ,  A61K31/423 ,  A61K31/435 ,  A61K31/4355 ,  A61K31/495 ,  A61K31/506 ,  A61K31/535 ,  A61K31/55 ,  A61P1/00 ,  A61P1/04 ,  A61P7/02 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P9/14 ,  A61P13/08 ,  A61P13/12 ,  A61P21/00 ,  A61P21/04 ,  A61P25/06 ,  A61P35/00 ,  A61P43/00 ,  C07D207/16 ,  C07D207/26 ,  C07D207/27 ,  C07D403/04 ,  C07D405/00 ,  C07D405/04 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14 ,  C07D491/056

Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof, is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.

公开(公告)号：CA2517691A1

公开(公告)日：1996-02-29

申请号：CA2517691

申请日：1995-08-04

Applicant: ABBOTT LAB

Inventor： BOYD STEVEN A ,  TASKER ANDREW S ,  SORENSEN BRYAN K ,  VONGELDERN THOMAS W ,  KESTER JEFFREY A ,  JAE HWAN-SOO ,  WINN MARTIN ,  HUTCHINS CHARLES W

IPC: A61K31/40 ,  A61K31/402 ,  A61K31/4025 ,  A61K31/403 ,  A61K31/41 ,  A61K31/415 ,  A61K31/422 ,  A61K31/435 ,  A61K31/44 ,  A61K31/4439 ,  A61K31/445 ,  A61K31/454 ,  A61K31/47 ,  A61K31/505 ,  A61K31/506 ,  A61K31/535 ,  A61K31/5377 ,  A61P9/00 ,  A61P9/04 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D20060101 ,  C07D207/14 ,  C07D207/16 ,  C07D401/04 ,  C07D403/04 ,  C07D405/04 ,  C07D405/10 ,  C07D405/14 ,  C07D413/04 ,  C07D419/04 ,  C07D471/04 ,  C07F9/572 ,  C07F9/59

Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.

公开(公告)号：CA2195677A1

公开(公告)日：1996-02-29

申请号：CA2195677

申请日：1995-08-04

Applicant: ABBOTT LAB

Inventor： WINN MARTIN ,  BOYD STEVEN A ,  HUTCHINS CHARLES W ,  JAE HWAN-SOO ,  TASKER ANDREW S ,  VONGELDERN THOMAS W ,  KESTER JEFFREY A ,  SORENSEN BRYAN K

IPC: A61K31/40 ,  A61K31/402 ,  A61K31/4025 ,  A61K31/403 ,  A61K31/41 ,  A61K31/415 ,  A61K31/422 ,  A61K31/435 ,  A61K31/44 ,  A61K31/4439 ,  A61K31/445 ,  A61K31/454 ,  A61K31/47 ,  A61K31/505 ,  A61K31/506 ,  A61K31/535 ,  A61K31/5377 ,  A61P9/00 ,  A61P9/04 ,  A61P9/08 ,  A61P9/10 ,  A61P9/12 ,  A61P29/00 ,  A61P35/00 ,  A61P43/00 ,  C07D20060101 ,  C07D207/14 ,  C07D207/16 ,  C07D401/04 ,  C07D403/04 ,  C07D405/04 ,  C07D405/10 ,  C07D405/14 ,  C07D413/04 ,  C07D419/04 ,  C07D471/04 ,  C07F9/572 ,  C07F9/59

Abstract: Processes for preparing endothelin antagonists of formula (I) and pharmaceutically acceptable salts thereof and processes for preparing intermediates thereof.

公开(公告)号：PT98685A

公开(公告)日：1992-07-31

申请号：PT9868591

申请日：1991-08-14

Applicant: ABBOTT LAB

Inventor： ROSENBERG SAUL H ,  DENISSEN JON F ,  BAKER WILLIAM R ,  FUNG ANTHONY K ,  BOYD STEVEN A ,  STEIN HERMAN H ,  HUTCHINS CHARLES W

IPC: A61K31/495 ,  A61K31/535 ,  A61K38/55 ,  C07D211/46 ,  C07D401/12 ,  C07D405/12 ,  C07D413/12 ,  C07D451/06 ,  C07D451/14 ,  C07D ,  A61K

Abstract: A renin inhibiting compound of the formula: (I) wherein X is O, NH or S and G is a mimic of the Leu-Val cleavage site of angiotensinogen; or a pharmaceutically acceptable salt, ester or prodrug thereof; with the proviso that the compound is not N-(3-(4-Morpholino)propyl)-5(S)-(2(S)-(1(S)-(4-methoxymethoxy)piperidin-1-yl)carbonyl-2-phenyl)ethoxyhexanamido)-6-cyclohexyl-4(S)-hydroxy-2(S)-isopropylhexanamide.

公开(公告)号：CA2808577C

公开(公告)日：2018-09-25

申请号：CA2808577

申请日：2011-08-19

Applicant: ABBOTT LAB

Inventor： BARBON JEFFREY A ,  CHHAYA MEHA ,  FUNG EMMA ,  HUTCHINS CHARLES W ,  LANG DIANE M ,  BARLOW EVE H ,  LEDDY MARY ,  CHARI RAVI ,  LACY SUSAN E

IPC: C07K16/22

Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and caninized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.

公开(公告)号：PH12013502359B1

公开(公告)日：2014-11-10

申请号：PH12013502359

申请日：2013-11-15

Applicant: ABBOTT GMBH & CO KG ,  ABBOTT LAB

Inventor： MACK HELMUT ,  KLING ANDREAS ,  JANTOS KATJA ,  MOELLER ACHIM ,  HORNBERGER WILFRIED ,  HUTCHINS CHARLES W

IPC: A61K31/4412 ,  C07D207/26 ,  C07D211/76 ,  C07D233/34 ,  C07D239/10

Abstract: The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity. The carboxamide compounds are compounds of the general formula (I) in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula (Ia) and (Ib) in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2-CH2, CH2-CH2-CH2, N(Ry#)-CH2, N(Ry#)-CH2-CH2 or CH=CH-CH=, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.